(0.10%) 5 251.75 points
(0.03%) 39 652 points
(0.22%) 18 295 points
(-0.04%) $78.23
(1.07%) $2.28
(-0.83%) $2 355.20
(-0.53%) $28.36
(0.15%) $1 008.70
(-0.02%) $0.928
(0.27%) $10.86
(0.01%) $0.798
(-0.94%) $91.80
Live Chart Being Loaded With Signals
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States...
Stats | |
---|---|
Today's Volume | 121 142 |
Average Volume | 345 104 |
Market Cap | 119.98M |
EPS | $0 ( 2024-05-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.72 |
ATR14 | $0.0170 (0.57%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-28 | Roberts Brian Kenneth | Buy | 500 | Common Shares |
2022-07-22 | Handok, Inc. | Buy | 3 157 895 | Common Shares |
2021-10-15 | Handok, Inc. | Buy | 769 231 | Common Shares |
2024-03-15 | Evans Daron | Buy | 20 000 | Common Shares |
2024-03-14 | Roberts Brian Kenneth | Buy | 10 000 | Common Shares |
INSIDER POWER |
---|
100.00 |
Last 96 transactions |
Buy: 107 305 216 | Sell: 58 571 575 |
Volume Correlation
Rezolute, Inc. Correlation
10 Most Positive Correlations | |
---|---|
XBIT | 0.97 |
MTEK | 0.968 |
VNOM | 0.967 |
FANG | 0.963 |
ENTX | 0.961 |
PRIM | 0.958 |
APP | 0.954 |
SVFAU | 0.954 |
IXAQ | 0.951 |
AEAC | 0.951 |
10 Most Negative Correlations | |
---|---|
HCDIP | -0.96 |
AKTX | -0.959 |
HAIN | -0.95 |
EMBC | -0.947 |
SPTN | -0.94 |
SHEN | -0.939 |
XPON | -0.936 |
UONEK | -0.934 |
PEAR | -0.934 |
BPTH | -0.933 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Rezolute, Inc. Correlation - Currency/Commodity
Rezolute, Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-382 000 (0.00 %) |
EPS: | $-1.010 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-382 000 (0.00 %) |
EPS: | $-1.010 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-256 000 (0.00 %) |
EPS: | $-2.13 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-2.72 |
Financial Reports:
No articles found.
Rezolute, Inc.
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, a selective and potent plasma kallikrein inhibitor, which is in Phase 1 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators